| 19/04/2024 |
08:30 to 10:00 |
Session I - Breast Cancer - Current Trends from Genetics to Oncologic Therapies
|
08:30 to 08:45 |
Correlations of Immunohistochemistry and Genetic Pathways with Molecular Imaging using New Radiotracers |
Speaker |
| 20/04/2024 |
08:30 to 10:00 |
SESSION I - The Role of Nuclear Medicine in Uterine Cancer |
09:00 to 09:15 |
Impact of Molecular Targets in Cervical Cancer |
Speaker |
| 20/04/2024 |
10:30 to 12:00 |
SESSION II - The Role of Nuclear Medicine in Ovarian Cancer |
11:00 to 11:20 |
The Impact on public health system with the insertion of Nuclear Medicine in female malignancies |
Speaker |
| 20/04/2024 |
10:30 to 12:00 |
SESSION II - The Role of Nuclear Medicine in Ovarian Cancer |
10:45 to 11:00 |
Molecular Imaging with PET/CT and Theranostics Possibilities in Ovarian Cancer |
Speaker |
